MorphoSys AG (NASDAQ:MOR)
| 24.45 Delayed Data As of Mar 31 |  -0.95 / -3.72%Today’s Change | 18.21 Today|||52-Week Range 37.96 | -31.46% Year-to-Date |
Latest MOR News | Press Releases
| MorphoSys AG (MOR) Q4 2019 Earnings Call Transcript Mar 19 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 25.52 |
| Today’s open | 24.87 |
| Day’s range | 24.37 - 25.06 |
| Volume | 50,177 |
| Average volume (3 months) | 100,072 |
| Market cap | $3.3B |
Data as of 3:47pm ET, 03/31/2020
Growth & Valuation
| Earnings growth (last year) | -72.49% |
| Earnings growth (this year) | +75.67% |
| Earnings growth (next 5 years) | +2.51% |
| Revenue growth (last year) | -10.95% |
| P/E ratio | NM |
| Price/Sales | 56.16 |
| Price/Book | 7.42 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NKTRNektar Therapeutics | -0.21 | -1.16% |
| BPMCBlueprint Medicines ... | +0.51 | +0.88% |
| MNTAMomenta Pharmaceutic... | -1.54 | -5.36% |
| ARWRArrowhead Pharmaceut... | -0.20 | -0.69% |
Data as of 4:00pm ET, 03/31/2020
Financials
| Next reporting date | May 7, 2020 |
| EPS forecast (this quarter) | $0.74 |
| Annual revenue (last year) | $80.3M |
| Annual profit (last year) | -$115.3M |
| Net profit margin | -143.56% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Planegg, Bayern (bavaria) |
Forecasts
